T1	PrimaryOutcome 90 127	Time to SARS-CoV-2 RNA negativization
T2	OutcomeDefinition 128 173	(absence of the virus according to the RT-PCR
R1	DefinedAs Arg1:T1 Arg2:T2	
T3	OutcomeDefinition 283 363	percentage of patients negative to SARS-CoV-2 by RT-PCR in throat exudate tissue
T4	TimeFrame 375 402	at 48, 72, 96 and 120 hours
R2	DefinedAs Arg1:T1 Arg2:T3	
R3	MeasuredAt Arg1:T1 Arg2:T4	
T5	PrimaryOutcome 573 592	clinical evaluation
T6	OutcomeDefinition 608 646	time to progression to severe COVID-19
T7	OutcomeDefinition 676 783	percentage of patients who became severely ill after the end of the antiviral treatment under investigation
R4	DefinedAs Arg1:T5 Arg2:T6	
R5	DefinedAs Arg1:T5 Arg2:T7	
